Molekulargenetik und die Bedeutung für hereditäre Augenerkrankungen

G. Rudolph

doi:10.1055/s-0033-1360401

Klinische Monatsblätter für Augenheilkunde, Inhaltsverzeichnis

Klin Monbl Augenheilkd 2014; 231(3): 208-209
DOI: 10.1055/s-0033-1360401

Editorial

Georg Thieme Verlag KG Stuttgart · New York

Molekulargenetik und die Bedeutung für hereditäre Augenerkrankungen

Molecular Genetics: Significance in Hereditary Eye Diseases

Autor*innen

G. Rudolph

Abstract

Volltext

Referenzen

Literatur
1 Glöckle N, Kohl S, Mohr J et al. Panel based next generation sequencing as a reliable and efficient technique to detect mutations in unselected patients with retinal dystrophies. Eur J Hum Genet 2014; 22: 99-104
2 Kohl S, Biskup S. Genetische Diagnostik bei erblichen Netzhautdystrophien. Klin Monatsbl Augenheilkd 2013; 230: 243-246
3 Thumann G. Prospectives for gene therapy of retinal degenerations. Curr Genomics 2012; 13: 350-362
4 Harding AE, Riordan-Eva P, Govan GG. Mitochondrial DNA diseases: genotype and phenotype in Leberʼs hereditary optic neuropathy. Muscle Nerve Suppl 1995; 3: S82-S84
5 Rudolph G, Dimitriadis K, Buchner B et al. Effects of Idebenone on colour vision in patients with Leber hereditary optic neuropathy. J Neuroophthalmol 2013; 33: 30-36
6 Klopstock T, Yu-Wai-Man P, Dimitriadis K et al. A randomized placebo-controlled trial of idebenone in Leberʼs hereditary optic neuropathy. Brain 2013; 136: e230
7 Trifunovic D, Sahaboglu A, Kaur J et al. Neuroprotective strategies for the treatment of inherited photoreceptor degeneration. Curr Mol Med 2012; 12: 598-612
8 Stieger K, Lorenz B. Gene therapy for vision loss – recent developments. Discov Med 2010; 10: 425-433
9 Millington-Ward S, Chadderton M, OʼReilly M et al. Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa. Mol Ther 2011; 19: 642-664
10 Michalakis S, Mühlfriedel R, Tanimoto N et al. Restoration of cone vision in the CNGA3-/- mouse model of congenital complete lack of cone photoreceptor function. Mol Ther 2010; 18: 2057-2063
11 Hauswirth WW, Aleman TS, Kaushal S et al. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther 2008; 19: 979-990
12 Testa F, Maguire AM, Rossi S et al. Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital amaurosis type 2. Ophthalmology 2013; 120: 1283-1291
13 Vasireddy V, Mills JA, Gaddameedi R et al. AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models. PLoS One 2013; 8: e61396
14 Lopes VS, Boye SE, Louie CM et al. Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus. Gene Ther 2013; 20: 824-833